Colgate-Palmolive (CL) Earns Hold Rating from Analysts at Deutsche Bank

Deutsche Bank started coverage on shares of Colgate-Palmolive (NYSE:CL) in a research report issued on Wednesday. The firm set a “hold” rating on the stock.

Other equities research analysts also recently issued research reports about the stock. Zacks Investment Research upgraded shares of Colgate-Palmolive from a “hold” rating to a “buy” rating and set a $80.00 price target for the company in a research report on Monday, September 25th. SunTrust Banks upgraded shares of Colgate-Palmolive from a “hold” rating to a “buy” rating and upped their price target for the company from $65.00 to $85.00 in a research report on Wednesday, October 11th. KeyCorp restated a “hold” rating on shares of Colgate-Palmolive in a research report on Monday, October 16th. Royal Bank of Canada restated a “hold” rating and issued a $74.00 price target on shares of Colgate-Palmolive in a research report on Sunday, October 8th. Finally, Jefferies Group restated a “hold” rating and issued a $79.00 price target on shares of Colgate-Palmolive in a research report on Thursday, September 28th. Two investment analysts have rated the stock with a sell rating, fifteen have issued a hold rating and four have assigned a buy rating to the stock. Colgate-Palmolive presently has an average rating of “Hold” and an average price target of $76.04.

Colgate-Palmolive (CL) traded up $0.86 during mid-day trading on Wednesday, reaching $73.35. 3,813,048 shares of the company traded hands, compared to its average volume of 3,605,857. Colgate-Palmolive has a fifty-two week low of $63.43 and a fifty-two week high of $77.27. The firm has a market capitalization of $64,410.00, a price-to-earnings ratio of 25.50, a PEG ratio of 3.35 and a beta of 0.81. The company has a current ratio of 1.23, a quick ratio of 0.92 and a debt-to-equity ratio of 24.42.

Colgate-Palmolive (NYSE:CL) last released its earnings results on Friday, October 27th. The company reported $0.73 EPS for the quarter, meeting the consensus estimate of $0.73. Colgate-Palmolive had a net margin of 15.10% and a return on equity of 2,782.56%. The business had revenue of $3.97 billion during the quarter, compared to analyst estimates of $3.94 billion. During the same period in the prior year, the business earned $0.73 earnings per share. The business’s quarterly revenue was up 2.8% on a year-over-year basis. equities analysts forecast that Colgate-Palmolive will post 2.88 earnings per share for the current year.

In other Colgate-Palmolive news, insider Victoria L. Dolan sold 10,000 shares of the company’s stock in a transaction that occurred on Thursday, November 9th. The shares were sold at an average price of $73.07, for a total value of $730,700.00. Following the transaction, the insider now owns 60,528 shares in the company, valued at approximately $4,422,780.96. The transaction was disclosed in a document filed with the SEC, which can be accessed through this link. Also, CMO Mukul Deoras sold 7,500 shares of the company’s stock in a transaction that occurred on Friday, November 10th. The shares were sold at an average price of $73.28, for a total transaction of $549,600.00. Following the completion of the transaction, the chief marketing officer now owns 45,217 shares in the company, valued at approximately $3,313,501.76. The disclosure for this sale can be found here. In the last quarter, insiders sold 173,673 shares of company stock worth $12,629,293. Company insiders own 1.02% of the company’s stock.

Several institutional investors and hedge funds have recently made changes to their positions in the company. Blue Chip Partners Inc. increased its stake in shares of Colgate-Palmolive by 0.4% during the 2nd quarter. Blue Chip Partners Inc. now owns 1,813 shares of the company’s stock worth $134,000 after purchasing an additional 8 shares during the last quarter. Cue Financial Group Inc. increased its stake in shares of Colgate-Palmolive by 0.3% during the 2nd quarter. Cue Financial Group Inc. now owns 4,854 shares of the company’s stock worth $360,000 after purchasing an additional 14 shares during the last quarter. Cornerstone Financial Partners LLC increased its stake in shares of Colgate-Palmolive by 0.5% during the 2nd quarter. Cornerstone Financial Partners LLC now owns 3,813 shares of the company’s stock worth $282,000 after purchasing an additional 19 shares during the last quarter. M Holdings Securities Inc. increased its stake in shares of Colgate-Palmolive by 0.4% during the 1st quarter. M Holdings Securities Inc. now owns 5,366 shares of the company’s stock worth $393,000 after purchasing an additional 21 shares during the last quarter. Finally, AlphaMark Advisors LLC grew its stake in Colgate-Palmolive by 1.5% in the 2nd quarter. AlphaMark Advisors LLC now owns 1,698 shares of the company’s stock valued at $126,000 after buying an additional 25 shares during the last quarter. Institutional investors own 72.96% of the company’s stock.

TRADEMARK VIOLATION WARNING: “Colgate-Palmolive (CL) Earns Hold Rating from Analysts at Deutsche Bank” was first posted by The Lincolnian Online and is owned by of The Lincolnian Online. If you are accessing this piece on another website, it was illegally stolen and reposted in violation of US and international copyright & trademark laws. The legal version of this piece can be accessed at https://www.thelincolnianonline.com/2017/12/13/colgate-palmolive-cl-earns-hold-rating-from-analysts-at-deutsche-bank.html.

About Colgate-Palmolive

Colgate-Palmolive Company (Colgate) is a consumer products company. The Company operates in two product segments: Oral, Personal and Home Care, and Pet Nutrition. The Oral, Personal and Home Care product segment is operated through five geographic segments, which include North America, Latin America, Europe, Asia Pacific and Africa/Eurasia.

Analyst Recommendations for Colgate-Palmolive (NYSE:CL)

Receive News & Ratings for Colgate-Palmolive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply